Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction

Journal of Cellular and Molecular Medicine
Maarten BrandtCaroline Cheng

Abstract

Obesity and hypertension are prevalent comorbidities in heart failure with preserved ejection fraction. To clarify if and how interaction between these comorbidities contributes to development of diastolic dysfunction, lean and obese ZSF1 rats were treated with deoxycorticosterone acetate implants and a high-salt diet (DS) to induce severe hypertension, or with placebo. In addition to echocardiographic, metabolic and hemodynamic analyses, immunohistochemistry and RNAseq were performed on left ventricular tissue. Obesity negatively affected cardiac output, led to an elevated E/e' ratio and mildly reduced ejection fraction. DS-induced hypertension did not affect cardiac output and minimally elevated E/e' ratio. Diastolic derangements in placebo-treated obese rats developed in absence of inflammation and fibrosis, yet in presence of oxidative stress and hypertrophic remodelling. In contrast, hypertension triggered apoptosis, inflammation and fibrosis, with limited synergy of the comorbidities observed for inflammation and fibrosis. Transcriptional data suggested that these comorbidities exerted opposite effects on mitochondrial function. In placebo-treated obese rats, genes involved in fatty acid metabolism were up-regulated, wher...Continue Reading

References

May 1, 1990·European Heart Journal·H Pouleur
Jun 1, 1994·The Journal of Clinical Investigation·M YoungJ Funder
Aug 28, 1998·Science·D R Green, J C Reed
Dec 9, 2003·The Journal of Physiology·Renée Ventura-ClapierVladimir Veksler
Jan 31, 2004·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Linley E WatsonDavid E Dostal
Sep 10, 2005·British Journal of Pharmacology·Anthony AllanLindsay Brown
Jan 18, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Justin L GrobeMichael J Katovich
Jul 10, 2007·Cell Metabolism·William A AlaynickRonald M Evans
Jul 10, 2007·Metabolism: Clinical and Experimental·Michael A MaloneJohn I Malone
Jul 11, 2007·TheScientificWorldJournal·Per Lindström
Jul 27, 2007·Echocardiography·Andrew T BurnsDavid L Prior
Feb 16, 2008·Circulation Research·Peter Zahradka
Mar 6, 2010·Annals of the New York Academy of Sciences·Heinrich TaegtmeyerDeborah Vela
Aug 11, 2010·Nature Reviews. Cardiology·Guido LastraJames R Sowers
Sep 11, 2010·American Journal of Physiology. Gastrointestinal and Liver Physiology·Sven WehnerJoerg C Kalff
Dec 9, 2010·European Heart Journal·Barry A Borlaug, Walter J Paulus
Mar 11, 2011·Clinical and Experimental Pharmacology & Physiology·Katsuyuki Ando, Megumi Fujita
Apr 20, 2011·Cardiovascular Research·Stephen C Kolwicz, Rong Tian
Feb 11, 2014·Cell Metabolism·Irfan J Lodhi, Clay F Semenkovich
Sep 17, 2014·Current Heart Failure Reports·Abhinav DhingraSunil K Agarwal
Nov 12, 2014·European Heart Journal·Alfonso EirinLilach O Lerman
Mar 31, 2015·PPAR Research·Domenick A ProsdocimoMukesh K Jain
Mar 2, 2016·American Journal of Hypertension·Wakako Kawarazaki, Toshiro Fujita
Dec 27, 2016·JACC. Cardiovascular Imaging·Scott D Solomon, Tor Biering-Sørensen
Apr 1, 2017·Journal of the American Heart Association·Jasper TrompAdriaan A Voors
Apr 18, 2017·Current Vascular Pharmacology·Costas TsioufisDimitrios Tousoulis
Sep 12, 2017·The Journal of Clinical Investigation·Hadi KhalilJeffery D Molkentin
Oct 6, 2017·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Massimo LeggioAndrea Mazza

❮ Previous
Next ❯

Methods Mentioned

BETA
RNAseq
dissect

Software Mentioned

Ingenuity Pathway Analysis
ARRIVE
Ingenuity Pathway Analysis ( IPA )

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis